Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion type Assertion NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_head.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion description "[These results indicate a dramatic improvement of antitumor activity; therefore, extensive utility of the newly designed uPA-targeted oncolytic SeV has significant potential for treating patients bearing urokinase-expressing cancers in clinical settings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_provenance.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion evidence source_evidence_literature NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_provenance.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion SIO_000772 19037241 NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_provenance.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion wasDerivedFrom befree-20140225 NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_provenance.
- NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_assertion wasGeneratedBy ECO_0000203 NP273203.RAT3UhmoRW1Y4Wn_S0oK2u9WzcFDqQgfeUUX63KQFFZZI130_provenance.